Targeting the Platelet Integrin GPIIb/IIIa

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|37|4119-4133

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.37, 2010-12, pp. : 4119-4133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Superiority of platelet integrin GPIIb-IIIa receptor antagonist over aspirin in preventing cyclic flow reductions in the guinea pig middle cerebral artery

By Kawano K.-i.   Ikeda Y.   Kondo K.   Umemura K.  

European Journal of Pharmacology, Vol. 374, Iss. 3, 1999-06 ,pp. : 377-385

Elsevier

Access to resources Recommend Favorite

Update on GPIIb/IIIa antagonists

By Hanson Julien   de Leval Xavier   Kolh Philippe   Supuran Claudiu   Pirotte Bernard   Dogné Jean-Michel  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 8, 2003-08 ,pp. : 1173-1188

Informa Healthcare

Access to resources Recommend Favorite

Antiplatelet Therapies: Platelet GPIIb / IIIa Antagonists and Beyond

By  

Current Pharmaceutical Design, Vol. 9, Iss. 28, 2003-11 ,pp. : 2317-2322

Bentham Science Publishers

Access to resources Recommend Favorite

UR-3216: A New Generation Oral Platelet GPIIb / IIIa Antagonist

By  

Current Pharmaceutical Design, Vol. 10, Iss. 14, 2004-05 ,pp. : 1597-1601

Bentham Science Publishers

Access to resources Recommend Favorite

Eptifibatide adds to inhibition of GPIIb-IIIa by clopidogrel

By  

Inpharma, Vol. 1, Iss. 1425, 2004-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite